Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine Endothelial cell specific molecule 1 (ESM1) ELISA Kit-Sandwich

Name: Canine Endothelial cell specific molecule 1 (ESM1) ELISA Kit-Sandwich
SKU: EK10F566
Rating: 5 (1 reviews)

Cat. No.EK10F566

Product TypeAnimal Immunoassay Kits

Size

Inquiry Now Add to Inquiry List

Product Overview

BioVenic Canine ESM1 ELISA Kit-Sandwich is designed for the quantitative determination of Canine endothelial cell specific molecule 1 (ESM1) in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich

Specificity The assay kit is specific for Canine ESM1.

Target Species Canine

Species Reactivity Canine

Detection Range 32-2000 pg/mL

Sensitivity 6.25 pg/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 180 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

Endothelial cell specific molecule 1 is encoded by the ESM1 gene in dogs. ESM-1 could be utilized as a new potential negative prognostic factor in canine myxomatous mitral valve disease.

Target/Biomarker Canine ESM1

Target Synonym endothelial cell specific molecule 1; endothelial cell-specific molecule 1

Gene ID 489201

UniProt ID A0A8C0LY83

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Hong, H.-J. et al. Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve disease. BMC Veterinary Research. 2022, 18: 261.